Skip to main content

Table 1 Descriptive statistics of patient characteristics at pre-treatment clinic visit

From: Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome

Measure

Lovastatin

Placebo

P value

N, enrolled

14

16

 

N, incomplete

2

0

 

Age

13.86 ± 2.14

13.17 ± 2.54

0.4307

Sex

0.2092

 Male

12

16

 Female

2

0

Race/ethnicity

0.05

 Caucasian

14

10

 Hispanic

0

4

 African American

0

1

 Asian

0

1

Leiter-R Brief IQ standard score

44.00 ± 9.22

43.13 ± 6.24

0.7604

Leiter-R growth score

461.40 ± 13.32

462.30 ± 8.57

0.8273

ADOS-2 comparison score

6.85 ± 2.54

6.75 ± 2.05

0.911

Parent education level

0.764

 HS grad/GED

0

1

 BA/BS

5

6

 Master’s degree +

4

4

 Some college

2

5

 Some grad work

1

0